Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 14 | 2019 | 596 | 1.980 |
Why?
|
| Cardiac Surgical Procedures | 13 | 2019 | 450 | 1.820 |
Why?
|
| Hypoplastic Left Heart Syndrome | 10 | 2015 | 138 | 1.790 |
Why?
|
| Norwood Procedures | 5 | 2017 | 61 | 1.380 |
Why?
|
| Heart Diseases | 6 | 2019 | 276 | 1.250 |
Why?
|
| Hospital Costs | 4 | 2018 | 117 | 1.240 |
Why?
|
| Postoperative Complications | 12 | 2019 | 1615 | 0.960 |
Why?
|
| Infant | 25 | 2019 | 2891 | 0.890 |
Why?
|
| Pediatrics | 3 | 2015 | 341 | 0.840 |
Why?
|
| Tetralogy of Fallot | 3 | 2018 | 43 | 0.790 |
Why?
|
| Fontan Procedure | 4 | 2011 | 129 | 0.770 |
Why?
|
| Cooperative Behavior | 4 | 2019 | 235 | 0.740 |
Why?
|
| Quality Improvement | 5 | 2019 | 413 | 0.710 |
Why?
|
| Cardiac Catheterization | 3 | 2016 | 419 | 0.700 |
Why?
|
| Pulmonary Artery | 5 | 2010 | 323 | 0.690 |
Why?
|
| Intensive Care Units | 5 | 2021 | 344 | 0.680 |
Why?
|
| Infant, Newborn | 21 | 2020 | 2455 | 0.680 |
Why?
|
| Cardiology | 3 | 2015 | 140 | 0.640 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2018 | 17 | 0.630 |
Why?
|
| Transposition of Great Vessels | 1 | 2018 | 51 | 0.600 |
Why?
|
| Databases, Factual | 6 | 2019 | 622 | 0.570 |
Why?
|
| Ventricular Pressure | 2 | 2016 | 82 | 0.550 |
Why?
|
| Health Expenditures | 1 | 2018 | 170 | 0.530 |
Why?
|
| Myocardial Contraction | 3 | 2016 | 383 | 0.530 |
Why?
|
| Registries | 7 | 2020 | 733 | 0.530 |
Why?
|
| Hospitals, Pediatric | 2 | 2016 | 114 | 0.530 |
Why?
|
| Echocardiography | 3 | 2016 | 515 | 0.520 |
Why?
|
| Length of Stay | 8 | 2017 | 780 | 0.500 |
Why?
|
| Heart Ventricles | 6 | 2012 | 738 | 0.500 |
Why?
|
| Ventricular Function, Left | 2 | 2016 | 481 | 0.490 |
Why?
|
| Microarray Analysis | 1 | 2014 | 63 | 0.480 |
Why?
|
| Chromosome Aberrations | 1 | 2014 | 86 | 0.480 |
Why?
|
| Cardiopulmonary Bypass | 4 | 2013 | 250 | 0.450 |
Why?
|
| Child, Preschool | 16 | 2019 | 3187 | 0.430 |
Why?
|
| Hypertension, Pulmonary | 2 | 2006 | 232 | 0.420 |
Why?
|
| Leadership | 1 | 2014 | 136 | 0.410 |
Why?
|
| Palliative Care | 4 | 2012 | 271 | 0.410 |
Why?
|
| Hospital Mortality | 8 | 2021 | 384 | 0.390 |
Why?
|
| Humans | 43 | 2021 | 68618 | 0.350 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2006 | 38 | 0.330 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 138 | 0.330 |
Why?
|
| Male | 27 | 2019 | 37321 | 0.330 |
Why?
|
| Child | 16 | 2021 | 6405 | 0.330 |
Why?
|
| Female | 25 | 2019 | 38074 | 0.310 |
Why?
|
| Postoperative Care | 3 | 2017 | 163 | 0.300 |
Why?
|
| Airway Extubation | 2 | 2018 | 17 | 0.300 |
Why?
|
| Retrospective Studies | 15 | 2018 | 7277 | 0.300 |
Why?
|
| Heart Bypass, Right | 1 | 2007 | 30 | 0.290 |
Why?
|
| Intensive Care Units, Pediatric | 4 | 2017 | 101 | 0.290 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 168 | 0.280 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2008 | 186 | 0.280 |
Why?
|
| Heart Valve Diseases | 1 | 2007 | 123 | 0.270 |
Why?
|
| Critical Care | 3 | 2019 | 263 | 0.270 |
Why?
|
| Extracorporeal Membrane Oxygenation | 4 | 2012 | 123 | 0.260 |
Why?
|
| Vasodilation | 1 | 2006 | 85 | 0.260 |
Why?
|
| Preoperative Care | 1 | 2007 | 275 | 0.250 |
Why?
|
| United States | 9 | 2019 | 7367 | 0.250 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2005 | 7 | 0.250 |
Why?
|
| Vasopressins | 1 | 2005 | 33 | 0.250 |
Why?
|
| Vasoconstrictor Agents | 1 | 2005 | 107 | 0.240 |
Why?
|
| Cardiomyopathies | 1 | 2006 | 167 | 0.230 |
Why?
|
| Nitric Oxide | 1 | 2006 | 382 | 0.230 |
Why?
|
| Research Design | 2 | 2020 | 729 | 0.210 |
Why?
|
| Treatment Outcome | 11 | 2015 | 7029 | 0.210 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2012 | 20 | 0.200 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2016 | 102 | 0.190 |
Why?
|
| Adolescent | 11 | 2017 | 8912 | 0.190 |
Why?
|
| Hospital Rapid Response Team | 1 | 2021 | 9 | 0.190 |
Why?
|
| Respiration, Artificial | 3 | 2017 | 190 | 0.190 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2020 | 9 | 0.180 |
Why?
|
| Heart Arrest | 1 | 2021 | 113 | 0.180 |
Why?
|
| Follow-Up Studies | 4 | 2016 | 3259 | 0.180 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 113 | 0.170 |
Why?
|
| Risk Factors | 9 | 2017 | 5731 | 0.170 |
Why?
|
| Blood Pressure | 2 | 2006 | 1451 | 0.170 |
Why?
|
| Cost Savings | 1 | 2020 | 110 | 0.170 |
Why?
|
| Heart Transplantation | 2 | 2014 | 328 | 0.170 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2010 | 72 | 0.170 |
Why?
|
| Efficiency, Organizational | 1 | 2019 | 61 | 0.160 |
Why?
|
| Aortic Coarctation | 1 | 2018 | 37 | 0.160 |
Why?
|
| Prospective Studies | 6 | 2016 | 3705 | 0.160 |
Why?
|
| Graft Rejection | 2 | 2014 | 458 | 0.140 |
Why?
|
| Insurance, Health | 1 | 2018 | 201 | 0.140 |
Why?
|
| Cost of Illness | 1 | 2018 | 206 | 0.140 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 177 | 0.140 |
Why?
|
| Intubation, Intratracheal | 1 | 2016 | 99 | 0.130 |
Why?
|
| Time Factors | 9 | 2018 | 4655 | 0.130 |
Why?
|
| Clinical Audit | 1 | 2015 | 2 | 0.130 |
Why?
|
| Data Accuracy | 1 | 2015 | 10 | 0.130 |
Why?
|
| Prenatal Diagnosis | 1 | 2015 | 73 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 848 | 0.130 |
Why?
|
| Vascular Resistance | 2 | 2006 | 179 | 0.120 |
Why?
|
| Learning | 1 | 2016 | 186 | 0.120 |
Why?
|
| Tricuspid Valve | 2 | 2013 | 42 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2007 | 277 | 0.120 |
Why?
|
| Hemodynamics | 4 | 2012 | 705 | 0.120 |
Why?
|
| HLA Antigens | 1 | 2014 | 82 | 0.120 |
Why?
|
| Health Care Rationing | 1 | 2014 | 32 | 0.110 |
Why?
|
| Genetic Testing | 1 | 2014 | 159 | 0.110 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2013 | 3 | 0.110 |
Why?
|
| Heart Injuries | 1 | 2013 | 25 | 0.110 |
Why?
|
| Multiple Trauma | 1 | 2013 | 50 | 0.110 |
Why?
|
| Survival Analysis | 3 | 2012 | 714 | 0.110 |
Why?
|
| Endpoint Determination | 1 | 2013 | 82 | 0.110 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 149 | 0.110 |
Why?
|
| Tissue Donors | 1 | 2014 | 195 | 0.100 |
Why?
|
| Anesthesia | 1 | 2014 | 120 | 0.100 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2013 | 131 | 0.100 |
Why?
|
| Tissue and Organ Procurement | 1 | 2014 | 164 | 0.100 |
Why?
|
| Cardiac Output, Low | 1 | 2012 | 52 | 0.100 |
Why?
|
| Risk Assessment | 3 | 2012 | 2007 | 0.100 |
Why?
|
| Child Development | 1 | 2012 | 102 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 772 | 0.100 |
Why?
|
| Developmental Disabilities | 1 | 2012 | 119 | 0.100 |
Why?
|
| Graft Survival | 1 | 2014 | 465 | 0.100 |
Why?
|
| Models, Neurological | 1 | 2012 | 136 | 0.100 |
Why?
|
| Terminal Care | 1 | 2012 | 92 | 0.100 |
Why?
|
| Age Factors | 2 | 2018 | 1864 | 0.100 |
Why?
|
| Young Adult | 3 | 2017 | 5717 | 0.090 |
Why?
|
| Monitoring, Intraoperative | 2 | 2008 | 53 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2010 | 536 | 0.090 |
Why?
|
| Anastomosis, Surgical | 2 | 2007 | 104 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2011 | 216 | 0.090 |
Why?
|
| Erythrocyte Transfusion | 1 | 2011 | 72 | 0.090 |
Why?
|
| Decision Making | 1 | 2014 | 410 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2014 | 310 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2012 | 222 | 0.090 |
Why?
|
| Patient Selection | 1 | 2014 | 592 | 0.090 |
Why?
|
| Quality of Health Care | 1 | 2012 | 322 | 0.080 |
Why?
|
| Plasma Substitutes | 1 | 2008 | 15 | 0.080 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 1046 | 0.080 |
Why?
|
| Survival Rate | 4 | 2014 | 1056 | 0.080 |
Why?
|
| Resuscitation | 1 | 2008 | 77 | 0.080 |
Why?
|
| Liver | 1 | 2013 | 1118 | 0.070 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2007 | 36 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2008 | 158 | 0.070 |
Why?
|
| Models, Cardiovascular | 1 | 2007 | 133 | 0.070 |
Why?
|
| Natriuretic Agents | 1 | 2006 | 9 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1465 | 0.070 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2006 | 32 | 0.070 |
Why?
|
| Pulmonary Veins | 1 | 2006 | 56 | 0.070 |
Why?
|
| Manikins | 1 | 2006 | 42 | 0.070 |
Why?
|
| Patient Care Planning | 1 | 2006 | 108 | 0.060 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2006 | 101 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2008 | 631 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2006 | 187 | 0.060 |
Why?
|
| Point-of-Care Systems | 1 | 2006 | 115 | 0.060 |
Why?
|
| Hypoxia | 1 | 2006 | 169 | 0.060 |
Why?
|
| Postoperative Period | 3 | 2012 | 238 | 0.060 |
Why?
|
| Vascular Patency | 1 | 2005 | 122 | 0.060 |
Why?
|
| Endocarditis, Bacterial | 1 | 2004 | 32 | 0.060 |
Why?
|
| Incidence | 3 | 2014 | 1603 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2006 | 586 | 0.060 |
Why?
|
| Biopsy | 1 | 2006 | 540 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2007 | 448 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2006 | 652 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2004 | 156 | 0.060 |
Why?
|
| Bacteremia | 1 | 2004 | 155 | 0.050 |
Why?
|
| Boston | 2 | 2014 | 35 | 0.050 |
Why?
|
| Cause of Death | 2 | 2012 | 241 | 0.050 |
Why?
|
| South Carolina | 2 | 2020 | 2752 | 0.050 |
Why?
|
| Adult | 5 | 2017 | 21403 | 0.050 |
Why?
|
| Models, Economic | 1 | 2020 | 69 | 0.040 |
Why?
|
| Markov Chains | 1 | 2020 | 133 | 0.040 |
Why?
|
| Morbidity | 1 | 2019 | 130 | 0.040 |
Why?
|
| Inpatients | 1 | 2021 | 208 | 0.040 |
Why?
|
| Perioperative Care | 2 | 2012 | 100 | 0.040 |
Why?
|
| Benchmarking | 1 | 2017 | 91 | 0.040 |
Why?
|
| Prognosis | 2 | 2012 | 2093 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2016 | 97 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 1745 | 0.030 |
Why?
|
| Ghana | 1 | 2014 | 40 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2011 | 2358 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2014 | 85 | 0.030 |
Why?
|
| Hospitals | 1 | 2015 | 265 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2013 | 133 | 0.030 |
Why?
|
| Hospitalization | 1 | 2018 | 978 | 0.030 |
Why?
|
| Infant Mortality | 1 | 2012 | 59 | 0.030 |
Why?
|
| North America | 1 | 2012 | 112 | 0.030 |
Why?
|
| Ventricular Function | 1 | 2012 | 93 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 2012 | 99 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 521 | 0.020 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2010 | 25 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 546 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2010 | 47 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 517 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 880 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 349 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2012 | 294 | 0.020 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2010 | 117 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 792 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1420 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2007 | 33 | 0.020 |
Why?
|
| Systole | 1 | 2007 | 149 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2008 | 284 | 0.020 |
Why?
|
| Diastole | 1 | 2007 | 161 | 0.020 |
Why?
|
| Observer Variation | 1 | 2006 | 330 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 362 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2006 | 59 | 0.020 |
Why?
|
| Insulin | 1 | 2008 | 619 | 0.020 |
Why?
|
| Heart Rate | 1 | 2007 | 568 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 334 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2007 | 601 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2008 | 506 | 0.020 |
Why?
|
| Critical Illness | 1 | 2006 | 191 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2004 | 175 | 0.010 |
Why?
|
| Inflammation | 1 | 2008 | 1030 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2006 | 657 | 0.010 |
Why?
|
| Stents | 1 | 2006 | 657 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 1851 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2077 | 0.010 |
Why?
|
| Prevalence | 1 | 2004 | 1619 | 0.010 |
Why?
|
| Middle Aged | 1 | 2009 | 21147 | 0.010 |
Why?
|